RGH Pharmacy E-Bulletin this
week discusses the use of iloprost
(Bayer’s Ventavis) in the treatment
of Raynaud’s phenomenon.
Iloprost is not currently registered
with the Australian Therapeutic
Goods Administration and can only
be accessed via category A Special
Access Scheme.
CLICK HERE to see the E-Bulletin.The above article was sent to subscribers in Pharmacy Daily's issue from 22 Jul 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Jul 14
THE Australian Commission on Safety and Quality in Health Care has today launched a national Standard to improve the care of people with cognitive disabilities or impairments.
AUSTRALIAN mothers and their babies experienced some positive outcomes during the early years of the pandemic, new research from the Australian Institute of Health and Welfare (AIHW) has discovered.
AUSTRALIA needs more pharmacists than ever, in the face of an ageing population and rising healthcare demands, according to the Pharmaceutical Society of Australia (PSA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.